Strolll has raised £10m in a funding round led by IW Capital. The company focuses on digital therapeutics, using augmented reality (AR) glasses to assist people with Parkinson's disease and multiple sclerosis.
Its technology enhances physiotherapy by integrating specially developed games, enabling clinicians to offer up to seven times more treatment with two-thirds less staff time.
The new capital will support sales and marketing expansion, product range extension, and targeting additional neuro-related disorders. The company is also conducting a £2.4m clinical trial with UK universities and NHS trusts and has entered the US market through a $3m collaboration with Cleveland Clinic.
